LabCorp to Buy Monogram – Analyst Blog
Zacks Market Commentaries (July 7th, 2009) Writes:
As per terms of the agreement, LabCorp's acquisition subsidiary Mastiff Acquisition Corp. has commenced a tender offer to purchase all outstanding shares of Monogram Biosciences for $4.55 per share in cash, without interest. Following completion of the tender offer, Mastiff and Monogram are expected to merge. The non-purchased shares will be converted into rights to receive equivalent cash value as in the tender offer.
Monogram is committed to advancing personalized medicine and improving patient outcomes through the development of innovative products that guide and target the most appropriate treatments. We are optimistic
...

![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)


